Last updated: February 3, 2025
Sponsor: University of North Carolina, Chapel Hill
Overall Status: Active - Recruiting
Phase
N/A
Condition
Anesthesia
Treatment
EMG Assessement of Recovery of Neuromuscular Function
Clinical Study ID
NCT06467448
24-1013
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Surgery and general anesthesia with administration of non depolarizing neuromuscularblocking drug
Exclusion
Exclusion Criteria:
neuromuscular disease or weakness of one of upper limbs.
Inability to use one of subjects arms to record neuromuscular monitor.
Contraindication to administration or allergy to non depolarizing neuromuscularblocking drug.
Study Design
Total Participants: 100
Treatment Group(s): 1
Primary Treatment: EMG Assessement of Recovery of Neuromuscular Function
Phase:
Study Start date:
June 18, 2024
Estimated Completion Date:
October 01, 2025
Study Description
Connect with a study center
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina 27599
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.